FIELD: medicine.
SUBSTANCE: group of inventions concerns the treatment of restless legs syndrome (RLS). The use of leucine, acetyleucine, or a pharmaceutically acceptable salt thereof for the treatment of RLS or one or more symptoms associated with RLS in a subject in need thereof, wherein RLS is the primary RLS are proposed. Also a method of alleviating, suppressing, or eliminating one or more RLS symptoms in a subject in need thereof is provided, the said method comprises administering a therapeutically effective amount of leucine, acetyleucine, or a pharmaceutically acceptable salt thereof to the subject.
EFFECT: use of the group of inventions provides effective treatment of RLS, in particular, reduction, suppression or elimination of one or more symptoms associated with RLS.
10 cl, 4 ex
